Ipilimumab augments antitumor activity of bispecific antibody-armed T cells - Test2 - elhamkhani - TriplyDB

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

http://www.wikidata.org/entity/Q33929184

about

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.Strategies and developments of immunotherapies in osteosarcoma Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer.B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.Checkpoint inhibitors in immunotherapy of ovarian cancer.Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.Emerging trends in the immunotherapy of pancreatic cancer.

P2860

Q34517676-C0F26F86-824A-4475-9A1F-3C2E19F939BB Q34548319-757D3BB8-3995-4207-8A32-33D277F52212 Q36503128-6BD5617C-2CCA-4440-A36D-107376A3507B Q36711013-DC83585B-101D-4260-97AA-BE0A76916C86 Q37301864-B0D65B11-3CF6-4971-B61B-0D951EE236C2 Q38269568-EA1A7E9A-99C4-4B41-94EF-DF354A0CD737 Q38400420-5CEC206E-F588-4344-AB34-F3BB78B13A71 Q38748299-47AAE870-E174-4870-8AB8-1457A0C86AD9 Q47248817-BE7EB539-BFC2-42EE-8331-399FE777D8D9

P2860

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

http://www.wikidata.org/entity/Q33929184

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@ast

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@en

type

label

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@ast

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@en

prefLabel

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@ast

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@en

P1433

Q33929184-8D7300DC-7919-43E8-9814-FC437719E66A

P1476

Q33929184-102BC762-32E5-407C-870F-029A3EB724E0

P2093

Q33929184-43E38643-BE9C-467E-A89C-626D2FB502D3

Q33929184-4EECC33A-A728-40DC-A42C-C0504608DA94

Q33929184-A3B7FB1B-5263-489B-AECA-4707DF878D6A

Q33929184-B404EB90-7D1D-4C85-BDD2-8CE44F425E3C

Q33929184-B7BB1441-1B34-4A4D-B7DC-B62101DD9E33

P2860

Q33929184-04095DC8-5ABA-43EB-9B93-509CE1C6C0DB

Q33929184-0CFABADB-A621-4F31-8EEB-CFF857698E4F

Q33929184-12FCBAF6-DEEA-4246-9AA3-364BC83D705A

Q33929184-133F4D4C-4CAC-481D-A57B-2CD9617D7C59

Q33929184-202CEDEA-0E65-4CCA-9CAC-003EA1EEAEE2

Q33929184-28AF37A0-EA51-4D68-9157-BF77A5FD8C2E

Q33929184-30281972-AE03-4172-ACEC-35C00C2409C7

Q33929184-3817D87D-326F-450D-996E-0C5DE1471F53

Q33929184-393854C4-DAFD-4DAC-83C7-8D43096CCDF9

Q33929184-3C3BDDD1-4BAA-46BD-A1D7-C815792CE7AC

P2888

Q33929184-3D132C33-F836-4724-90E5-1C4B6E70DCB4

P304

Q33929184-469BA8F9-3822-414E-B142-C8B117DEB9FD

P31

Q33929184-92263B53-6294-4CD2-97B9-52A6D4770B92

P356

Q33929184-15D28398-C529-4ED8-8F5B-706DA7A2D118

P478

Q33929184-232981E2-079D-4B33-A4D3-B806F61A22D8

P50

Q33929184-1BE35CB8-B4CB-4877-A229-561EEBDF7D80

P577

Q33929184-B4C7556C-2711-458A-A8F4-BE6707EE9ADF

P5875

Q33929184-1B706FFD-F63B-4C23-935D-D875F857B04B

P6179

Q33929184-F42CA1FE-E4D4-4FF7-BED7-80D044C309C9

P698

Q33929184-70095AF7-147E-418F-B28C-0A3412797E7F

P921

Q33929184-419F72CE-5EEE-48AB-9ED6-29143C8B50C3

P932

Q33929184-94DFE21C-F398-4B01-AC93-A5A18690D651

P356

1479-5876-12-191

P1433

Journal of Translational Medicine

P1476

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

@en

P2093

Abhinav Deol

http://www.w3.org/2001/XMLSchema#string

Archana Thakur

http://www.w3.org/2001/XMLSchema#string

Elyse N Tomaszewski

http://www.w3.org/2001/XMLSchema#string

Lawrence G Lum

http://www.w3.org/2001/XMLSchema#string

Minsig Choi

http://www.w3.org/2001/XMLSchema#string

P2860

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

CTLA-4 can function as a negative regulator of T cell activation

Enhancement of antitumor immunity by CTLA-4 blockade

Anthropometric reference data for children and adults: United States, 2007-2010.

IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection.

The role of interleukin-2 during homeostasis and activation of the immune system.

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies.

P2888

1479-5876-12-191

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-12-191

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263815988

http://www.w3.org/2001/XMLSchema#string

P6179

1023614955

http://www.w3.org/2001/XMLSchema#string

P698

25008236

http://www.w3.org/2001/XMLSchema#string

P921

P932

4105782

http://www.w3.org/2001/XMLSchema#string